Apogee Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $93,003,000.
Profit Margin
| 2022 | 0 | -39.78M | |
|---|---|---|---|
| 2023 | 0 | -83.98M |
APGE Income Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Revenue | ||
Revenue | 0 | 0 |
Cost of revenue | 0 | 0 |
Gross profit | 0 | 0 |
Operating exp. | ||
Research and development | 68.42M | 27.78M |
Selling and marketing | 0 | 0 |
Total operating expenses | 93.00M | 30.72M |
Operating income | -93.00M | -30.72M |
Other income (expenses), net | 9.01M | -9.05M |
Income before tax | -83.98M | -39.78M |
Income tax expense | 0 | -33.52K |
Net income | -83.98M | -39.78M |
Earnings per share | ||
Basic EPS | -0.00 | -0.79 |
Diluted EPS | -0.00 | -0.79 |
| Data source |